|
|
| See related calcium lactate information |
|
| Nutritional supplement. |
| PO 19-50 yr: 1,000 mg elemental Ca/day and >50 yr: 1,200 mg elemental Ca/day.
Click to view Dosage by Indications |
| Should be taken with food. |
| Conditions associated with hypercalcaemia and hypercalciuria. |
| Renal impairment (frequent monitoring of serum calcium and phosphorus is recommended); sarcoidosis; history of nephrolithiasis. Avoid IV admin of calcium in patients on cardiac glycosides. Increased risk of hypercalcaemia and hypercalciuria in hypoparathyroid patients receiving high doses of vitamin D. Caution when used in patients with history of kidney stones. Patients should be advised to administer vitamin D concurrently to optimise calcium absorption. Pregnancy. |
| GI discomfort e.g. nausea, vomiting, constipation; bradycardia, arrhythmias. Dry mouth, increased thirst or increased urination. Mental confusion, milk-alkali syndrome. |
| May reduce the efficacy of calcium-channel blockers. Concurrent admin of IV calcium salt with cardiac glycosides may lead to serious adverse events. Increased risk of hypercalcaemia when used with thiazide diuretics. May reduce absorption of tetracycline, alendronate, atenolol, iron, quinolone antibiotics, sodium fluoride and zinc.
Click to view more Drug Interactions |
| For caution against potential drug-food interactions ... click to view |
|
| Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
| For details of the mechanism of action, pharmacology and pharmacokinetics and toxicology ... click to view |
| Electrolytes |
| A12AA05 - Calcium lactate; Belongs to the class of calcium-containing preparations used as dietary supplements | . |
|
No comments:
Post a Comment